Scigenom Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 18-12-2024
- Paid Up Capital ₹ 4.96 M
as on 18-12-2024
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.43 Cr
as on 18-12-2024
- Revenue 4.95%
(FY 2023)
- Profit -573.29%
(FY 2023)
- Ebitda -2456.28%
(FY 2023)
- Net Worth -311.12%
(FY 2023)
- Total Assets -45.93%
(FY 2023)
About Scigenom Labs
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.96 M.
The company currently has active open charges totaling ₹4.43 Cr.
Sreedhar Santhosh and Balamaniamma Nair serve as directors at the Company.
- CIN/LLPIN
U73200KL2009PTC039290
- Company No.
039290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Scigenom Labs Private Limited offer?
Scigenom Labs Private Limited offers a wide range of products and services, including Diagnostic Imaging & Pathology Labs, Medical Test Services, Medical Consultants & Clinics, Medical Consultancy Services, Computer and Mobile Softwares & Apps, ERP Packages.
Who are the key members and board of directors at Scigenom Labs?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreedhar Santhosh  | Managing Director | 15-Feb-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Balamaniamma Nair | Director | 17-Apr-2009 | Current |
Financial Performance and Corporate Structure Insights of Scigenom Labs.
Scigenom Labs Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.95% increase. The company also saw a substantial fall in profitability, with a 573.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 311.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scigenom Labs?
In 2023, Scigenom Labs had a public holding of 32.92%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agrigenome Labs Private LimitedActive 9 years 3 monthsSreedhar Santhosh and Balamaniamma Nair are mutual person
Maggenome Technologies Private LimitedActive 9 years 6 monthsSreedhar Santhosh and Balamaniamma Nair are mutual person
Medgenome Labs LimitedActive 11 years 8 monthsSreedhar Santhosh and Balamaniamma Nair are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Biotechnology Industry Research Assistance Council Creation Date: 22 Dec 2014 | ₹1.13 Cr | Open |
Biotechnology Industry Research Assistance Council Creation Date: 01 Apr 2014 | ₹3.00 M | Open |
Hdfc Bank Limited Creation Date: 17 May 2013 | ₹3.00 Cr | Open |
How Many Employees Work at Scigenom Labs?
Scigenom Labs has a workforce of 12 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scigenom Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scigenom Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
